Membranoproliferative glomerulonephritis (MPGN) and C3 glomerulopathy (C3G) define a
disease pattern characterized by proteinuria, hypertension and impaired kidney function …

Whereas early classifications of membranoproliferative glomerulonephritis (MPGN) were
based on morphologic features, the modern approach is directed at immunofluorescence …

Recent advances in our understanding of the disease pathology of membranoproliferative
glomerulonephritis has resulted in its re-classification as complement C3 glomerulopathy …

Based on new pathophysiological discoveries in recent years, a new classification of
glomerulonephritis with dominant or codominant C3 deposits was introduced in 2010, which …

The diagnosis of membranoproliferative glomerulonephritis (MPGN) has recently undergone
change from an electron microscopy-based classification scheme to one based largely on …

C3 glomerulopathy defi nes a group of diseases characterized with deposition of C3 alone
in the glomeruli in the absence of deposition of immunoglobulin or other complement …

Understanding the role of alternative complement pathway dysregulation in
membranoproliferative glomerulonephritis (MPGN) has led to a new classification into two …

Abstract Background Complement 3 glomerulopathy (C3GN) is a newly proposed
subcategory of glomerular disease with features including membranoproliferative …

Membranoproliferative glomerulonephritis (MPGN) and glomerulopathy with dominant C3
deposits are very rare autoimmune disorders of the kidney that had been classified in its …

Membranoproliferative glomerulonephritis (MPGN) is an uncommon cause of glomerular
injury that mainly occurs in children and young adults. MPGN is currently classified in …